Galimzianov Kh M, Rasskazov N I, Altukhov S A, Mesniankin A P, Afanas'ev S S, Denisov L A
Ter Arkh. 1996;68(2):65-6.
Astrakhan fever is a new endemic rickettsiosis belonging to the group of tick-borne spotted fevers. Adjuvant use of interferons in basic treatment of Astrakhan fever elevates its efficacy. The maximal contribution of interferons can be reached at administration of alpha-2 and gamma-interferons in daily doses 15,000-25,000 and 1500-2500 IU/kg, respectively. The response is higher at early administration of the medication. Interferons induce side effects early in the course: intensification of hyperthermia and pains.
阿斯特拉罕热是一种新的地方性立克次体病，属于蜱传斑点热组。在阿斯特拉罕热的基础治疗中辅助使用干扰素可提高其疗效。分别以每日15000 - 25000 IU/kg和1500 - 2500 IU/kg的剂量给予α-2干扰素和γ-干扰素时，可达到干扰素的最大作用效果。在早期给药时反应更高。干扰素在病程早期会引起副作用：体温过高和疼痛加剧。
